ESMO 2018 News

ESMO 2018 News

Episodes

Specialty:

All

Year:

All

EP. 1: OncLive News Network On Location: In Munich Saturday, October 20

October 20th 2018

EP. 2: OncLive News Network On Location: In Munich Sunday, October 21

October 20th 2018

EP. 3: OncLive News Network On Location: In Munich Monday, October 22

October 20th 2018

EP. 4: ESMO 2018: Dr. Moore Speaks to Exciting PARP Inhibitor Abstracts in Ovarian Cancer

October 20th 2018

EP. 5: ESMO 2018: Dr. George Highlights Key Abstracts in Kidney and Prostate Cancers

October 20th 2018

EP. 6: ESMO 2018: Dr. Cohen Reflects on Practice-Changing Data in Head and Neck Cancer

October 20th 2018

EP. 7: ESMO 2018: Dr. Abou-Alfa Discusses Updates in GI Cancer

October 20th 2018

EP. 8: ESMO 2018: Dr. Ramalingam Shares Insight on Lung Cancer Studies

October 20th 2018

EP. 9: ESMO 2018: Dr. Verma Sheds Light on Breast Cancer Data

October 20th 2018

Trending on OncLive

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC

Novel Therapies Are Poised to Answer Questions and Reinvigorate Hematologic Oncology at SOHO 2026

Etentamig Meets PFS, ORR Primary End Points in Triple-Class Exposed R/R Myeloma